Oculis Holding AG (OCS) Free Cash Flow (2022 - 2026)
Quarterly Free Cash Flow rose 7.12% to -$19.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$77.7 million through Mar 2026, down 28.08% year-over-year, with the annual reading at -$82.6 million for FY2025, 48.58% down from the prior year.
Oculis Holding AG's Free Cash Flow history spans 5 years, with the latest figure at -$19.6 million for Q1 2026.
- Free Cash Flow came in at -$19.6 million for Q1 2026, up from -$20.8 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$6.8 million in Q4 2022 to a low of -$21.1 million in Q1 2025.
- The 5-year median for Free Cash Flow is -$15.7 million (2024), against an average of -$15.3 million.
- Year-over-year, Free Cash Flow tumbled 136.64% in 2023 and then rose 24.53% in 2024.
- Oculis Holding AG's Free Cash Flow stood at -$6.8 million in 2022, then crashed by 136.64% to -$16.0 million in 2023, then grew by 24.53% to -$12.1 million in 2024, then plummeted by 72.3% to -$20.8 million in 2025, then grew by 5.99% to -$19.6 million in 2026.
- Per Business Quant, the three most recent readings for OCS's Free Cash Flow are -$19.6 million (Q1 2026), -$20.8 million (Q4 2025), and -$16.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 848.30 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Oculis Holding AG | 24.51 Bn | 24.21 Bn | - | -19.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.58 Mn |
| Mar 31, 2026 | -19.58 Mn |
| Dec 31, 2025 | -20.82 Mn |
| Dec 31, 2025 | -20.82 Mn |
| Sep 30, 2025 | -16.62 Mn |
| Sep 30, 2025 | -16.62 Mn |
| Jun 30, 2025 | -20.67 Mn |
| Jun 30, 2025 | -20.67 Mn |
| Mar 31, 2025 | -21.08 Mn |
| Mar 31, 2025 | -21.08 Mn |
| Dec 31, 2024 | -12.09 Mn |
| Dec 31, 2024 | -12.09 Mn |
| Sep 30, 2024 | -12.31 Mn |
| Sep 30, 2024 | -12.31 Mn |
| Jun 30, 2024 | -15.19 Mn |
| Jun 30, 2024 | -15.19 Mn |
| Mar 31, 2024 | -15.72 Mn |
| Mar 31, 2024 | -15.72 Mn |
| Dec 31, 2023 | -16.01 Mn |
| Dec 31, 2023 | -16.01 Mn |
| Sep 30, 2023 | -13.54 Mn |
| Sep 30, 2023 | -13.54 Mn |
| Jun 30, 2023 | -14.71 Mn |
| Jun 30, 2023 | -14.71 Mn |
| Mar 31, 2023 | -16.89 Mn |
| Mar 31, 2023 | -16.89 Mn |
| Dec 31, 2022 | -6.77 Mn |
| Dec 31, 2022 | -6.77 Mn |
| Sep 30, 2022 | -7.14 Mn |
| Sep 30, 2022 | -7.14 Mn |